The transcription factor IRF4 represses proapoptotic BMF and BIM to licence multiple myeloma survival
Gespeichert in:
| Veröffentlicht in: | Leukemia 2021-07, Vol.35 (7), p.2114-2118 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2118 |
|---|---|
| container_issue | 7 |
| container_start_page | 2114 |
| container_title | Leukemia |
| container_volume | 35 |
| creator | Fedele, Pasquale L. Liao, Yang Gong, Jia-nan Yao, Yuan van Delft, Mark F. Low, Michael S. Y. Tai, Lin Herold, Marco J. Jackson, Jacob T. Teh, Charis E. Tan, Tania O’Reilly, Lorraine A. Tellier, Julie Grigoriadis, George Huang, David C. S. Shi, Wei Nutt, Stephen L. Willis, Simon N. |
| description | |
| doi_str_mv | 10.1038/s41375-020-01078-0 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2457969695</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A667501888</galeid><sourcerecordid>A667501888</sourcerecordid><originalsourceid>FETCH-LOGICAL-c450t-cd431d3a24615e9f73585c414efb2f029dbeba5f09cd40b0b61ed282b0996bb53</originalsourceid><addsrcrecordid>eNp9kcFq3DAQhk1podskL9CToFB6cTKSJVs-JqHbLiQESnIWsjzOKsiWK8mBvH3lbiFNKGUOM4y-fxjNXxQfKZxSqORZ5LRqRAkMSqDQyBLeFBvKm7oUQtC3xQakbMq6Zfx98SHGB4D1sd4UeLtHkoKeogl2TtZPZNAm-UB2P7acBJwDxoiRzMHr2c_JJ2vIxfWW6KknF7trkjxx1uBkkIyLS3Z2uXhC50dN4hIe7aN2x8W7QbuIJ3_yUXG3_Xp7-b28uvm2uzy_Kg0XkErT84r2lWa8pgLboamEFIZTjkPHBmBt32GnxQBtJqGDrqbYM8k6aNu660R1VHw5zM3b_lwwJjXaaNA5PaFfomJcNG2dY0U_vUIf_BKmvJ1igstKypbSZ-peO1R2Gny-lVmHqvO6bgRQKWWmTv9B5ehxtMZPONjcfyH4_Jdgj9qlffRuWe8fX4LsAJrgYww4qDnYUYcnRUGtzquD8yo7r347ryCLqoMoZni6x_D8tf-ofgHSHq6x</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2548388911</pqid></control><display><type>article</type><title>The transcription factor IRF4 represses proapoptotic BMF and BIM to licence multiple myeloma survival</title><source>Alma/SFX Local Collection</source><creator>Fedele, Pasquale L. ; Liao, Yang ; Gong, Jia-nan ; Yao, Yuan ; van Delft, Mark F. ; Low, Michael S. Y. ; Tai, Lin ; Herold, Marco J. ; Jackson, Jacob T. ; Teh, Charis E. ; Tan, Tania ; O’Reilly, Lorraine A. ; Tellier, Julie ; Grigoriadis, George ; Huang, David C. S. ; Shi, Wei ; Nutt, Stephen L. ; Willis, Simon N.</creator><creatorcontrib>Fedele, Pasquale L. ; Liao, Yang ; Gong, Jia-nan ; Yao, Yuan ; van Delft, Mark F. ; Low, Michael S. Y. ; Tai, Lin ; Herold, Marco J. ; Jackson, Jacob T. ; Teh, Charis E. ; Tan, Tania ; O’Reilly, Lorraine A. ; Tellier, Julie ; Grigoriadis, George ; Huang, David C. S. ; Shi, Wei ; Nutt, Stephen L. ; Willis, Simon N.</creatorcontrib><identifier>ISSN: 0887-6924</identifier><identifier>EISSN: 1476-5551</identifier><identifier>DOI: 10.1038/s41375-020-01078-0</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>38/39 ; 38/91 ; 631/67/1990/804 ; 631/80/82/23 ; 96/2 ; Ablation ; Apoptosis ; Cancer ; Cancer Research ; Cell cycle ; CRISPR ; Critical Care Medicine ; Development and progression ; Gene expression ; Genetic aspects ; Health aspects ; Hematology ; Intensive ; Interferon regulatory factor 4 ; Internal Medicine ; Letter ; Medical research ; Medicine ; Medicine & Public Health ; Multiple myeloma ; Oncology ; Oncology, Experimental ; Transcription factors</subject><ispartof>Leukemia, 2021-07, Vol.35 (7), p.2114-2118</ispartof><rights>Springer Nature Limited 2020</rights><rights>COPYRIGHT 2021 Nature Publishing Group</rights><rights>Springer Nature Limited 2020.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c450t-cd431d3a24615e9f73585c414efb2f029dbeba5f09cd40b0b61ed282b0996bb53</citedby><cites>FETCH-LOGICAL-c450t-cd431d3a24615e9f73585c414efb2f029dbeba5f09cd40b0b61ed282b0996bb53</cites><orcidid>0000-0002-0020-6637 ; 0000-0003-3999-8309 ; 0000-0002-6396-2739 ; 0000-0002-3101-4873 ; 0000-0001-7330-1275</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Fedele, Pasquale L.</creatorcontrib><creatorcontrib>Liao, Yang</creatorcontrib><creatorcontrib>Gong, Jia-nan</creatorcontrib><creatorcontrib>Yao, Yuan</creatorcontrib><creatorcontrib>van Delft, Mark F.</creatorcontrib><creatorcontrib>Low, Michael S. Y.</creatorcontrib><creatorcontrib>Tai, Lin</creatorcontrib><creatorcontrib>Herold, Marco J.</creatorcontrib><creatorcontrib>Jackson, Jacob T.</creatorcontrib><creatorcontrib>Teh, Charis E.</creatorcontrib><creatorcontrib>Tan, Tania</creatorcontrib><creatorcontrib>O’Reilly, Lorraine A.</creatorcontrib><creatorcontrib>Tellier, Julie</creatorcontrib><creatorcontrib>Grigoriadis, George</creatorcontrib><creatorcontrib>Huang, David C. S.</creatorcontrib><creatorcontrib>Shi, Wei</creatorcontrib><creatorcontrib>Nutt, Stephen L.</creatorcontrib><creatorcontrib>Willis, Simon N.</creatorcontrib><title>The transcription factor IRF4 represses proapoptotic BMF and BIM to licence multiple myeloma survival</title><title>Leukemia</title><addtitle>Leukemia</addtitle><subject>38/39</subject><subject>38/91</subject><subject>631/67/1990/804</subject><subject>631/80/82/23</subject><subject>96/2</subject><subject>Ablation</subject><subject>Apoptosis</subject><subject>Cancer</subject><subject>Cancer Research</subject><subject>Cell cycle</subject><subject>CRISPR</subject><subject>Critical Care Medicine</subject><subject>Development and progression</subject><subject>Gene expression</subject><subject>Genetic aspects</subject><subject>Health aspects</subject><subject>Hematology</subject><subject>Intensive</subject><subject>Interferon regulatory factor 4</subject><subject>Internal Medicine</subject><subject>Letter</subject><subject>Medical research</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Multiple myeloma</subject><subject>Oncology</subject><subject>Oncology, Experimental</subject><subject>Transcription factors</subject><issn>0887-6924</issn><issn>1476-5551</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kcFq3DAQhk1podskL9CToFB6cTKSJVs-JqHbLiQESnIWsjzOKsiWK8mBvH3lbiFNKGUOM4y-fxjNXxQfKZxSqORZ5LRqRAkMSqDQyBLeFBvKm7oUQtC3xQakbMq6Zfx98SHGB4D1sd4UeLtHkoKeogl2TtZPZNAm-UB2P7acBJwDxoiRzMHr2c_JJ2vIxfWW6KknF7trkjxx1uBkkIyLS3Z2uXhC50dN4hIe7aN2x8W7QbuIJ3_yUXG3_Xp7-b28uvm2uzy_Kg0XkErT84r2lWa8pgLboamEFIZTjkPHBmBt32GnxQBtJqGDrqbYM8k6aNu660R1VHw5zM3b_lwwJjXaaNA5PaFfomJcNG2dY0U_vUIf_BKmvJ1igstKypbSZ-peO1R2Gny-lVmHqvO6bgRQKWWmTv9B5ehxtMZPONjcfyH4_Jdgj9qlffRuWe8fX4LsAJrgYww4qDnYUYcnRUGtzquD8yo7r347ryCLqoMoZni6x_D8tf-ofgHSHq6x</recordid><startdate>20210701</startdate><enddate>20210701</enddate><creator>Fedele, Pasquale L.</creator><creator>Liao, Yang</creator><creator>Gong, Jia-nan</creator><creator>Yao, Yuan</creator><creator>van Delft, Mark F.</creator><creator>Low, Michael S. Y.</creator><creator>Tai, Lin</creator><creator>Herold, Marco J.</creator><creator>Jackson, Jacob T.</creator><creator>Teh, Charis E.</creator><creator>Tan, Tania</creator><creator>O’Reilly, Lorraine A.</creator><creator>Tellier, Julie</creator><creator>Grigoriadis, George</creator><creator>Huang, David C. S.</creator><creator>Shi, Wei</creator><creator>Nutt, Stephen L.</creator><creator>Willis, Simon N.</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T5</scope><scope>7T7</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-0020-6637</orcidid><orcidid>https://orcid.org/0000-0003-3999-8309</orcidid><orcidid>https://orcid.org/0000-0002-6396-2739</orcidid><orcidid>https://orcid.org/0000-0002-3101-4873</orcidid><orcidid>https://orcid.org/0000-0001-7330-1275</orcidid></search><sort><creationdate>20210701</creationdate><title>The transcription factor IRF4 represses proapoptotic BMF and BIM to licence multiple myeloma survival</title><author>Fedele, Pasquale L. ; Liao, Yang ; Gong, Jia-nan ; Yao, Yuan ; van Delft, Mark F. ; Low, Michael S. Y. ; Tai, Lin ; Herold, Marco J. ; Jackson, Jacob T. ; Teh, Charis E. ; Tan, Tania ; O’Reilly, Lorraine A. ; Tellier, Julie ; Grigoriadis, George ; Huang, David C. S. ; Shi, Wei ; Nutt, Stephen L. ; Willis, Simon N.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c450t-cd431d3a24615e9f73585c414efb2f029dbeba5f09cd40b0b61ed282b0996bb53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>38/39</topic><topic>38/91</topic><topic>631/67/1990/804</topic><topic>631/80/82/23</topic><topic>96/2</topic><topic>Ablation</topic><topic>Apoptosis</topic><topic>Cancer</topic><topic>Cancer Research</topic><topic>Cell cycle</topic><topic>CRISPR</topic><topic>Critical Care Medicine</topic><topic>Development and progression</topic><topic>Gene expression</topic><topic>Genetic aspects</topic><topic>Health aspects</topic><topic>Hematology</topic><topic>Intensive</topic><topic>Interferon regulatory factor 4</topic><topic>Internal Medicine</topic><topic>Letter</topic><topic>Medical research</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Multiple myeloma</topic><topic>Oncology</topic><topic>Oncology, Experimental</topic><topic>Transcription factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fedele, Pasquale L.</creatorcontrib><creatorcontrib>Liao, Yang</creatorcontrib><creatorcontrib>Gong, Jia-nan</creatorcontrib><creatorcontrib>Yao, Yuan</creatorcontrib><creatorcontrib>van Delft, Mark F.</creatorcontrib><creatorcontrib>Low, Michael S. Y.</creatorcontrib><creatorcontrib>Tai, Lin</creatorcontrib><creatorcontrib>Herold, Marco J.</creatorcontrib><creatorcontrib>Jackson, Jacob T.</creatorcontrib><creatorcontrib>Teh, Charis E.</creatorcontrib><creatorcontrib>Tan, Tania</creatorcontrib><creatorcontrib>O’Reilly, Lorraine A.</creatorcontrib><creatorcontrib>Tellier, Julie</creatorcontrib><creatorcontrib>Grigoriadis, George</creatorcontrib><creatorcontrib>Huang, David C. S.</creatorcontrib><creatorcontrib>Shi, Wei</creatorcontrib><creatorcontrib>Nutt, Stephen L.</creatorcontrib><creatorcontrib>Willis, Simon N.</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing & Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Leukemia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fedele, Pasquale L.</au><au>Liao, Yang</au><au>Gong, Jia-nan</au><au>Yao, Yuan</au><au>van Delft, Mark F.</au><au>Low, Michael S. Y.</au><au>Tai, Lin</au><au>Herold, Marco J.</au><au>Jackson, Jacob T.</au><au>Teh, Charis E.</au><au>Tan, Tania</au><au>O’Reilly, Lorraine A.</au><au>Tellier, Julie</au><au>Grigoriadis, George</au><au>Huang, David C. S.</au><au>Shi, Wei</au><au>Nutt, Stephen L.</au><au>Willis, Simon N.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The transcription factor IRF4 represses proapoptotic BMF and BIM to licence multiple myeloma survival</atitle><jtitle>Leukemia</jtitle><stitle>Leukemia</stitle><date>2021-07-01</date><risdate>2021</risdate><volume>35</volume><issue>7</issue><spage>2114</spage><epage>2118</epage><pages>2114-2118</pages><issn>0887-6924</issn><eissn>1476-5551</eissn><cop>London</cop><pub>Nature Publishing Group UK</pub><doi>10.1038/s41375-020-01078-0</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0002-0020-6637</orcidid><orcidid>https://orcid.org/0000-0003-3999-8309</orcidid><orcidid>https://orcid.org/0000-0002-6396-2739</orcidid><orcidid>https://orcid.org/0000-0002-3101-4873</orcidid><orcidid>https://orcid.org/0000-0001-7330-1275</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0887-6924 |
| ispartof | Leukemia, 2021-07, Vol.35 (7), p.2114-2118 |
| issn | 0887-6924 1476-5551 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2457969695 |
| source | Alma/SFX Local Collection |
| subjects | 38/39 38/91 631/67/1990/804 631/80/82/23 96/2 Ablation Apoptosis Cancer Cancer Research Cell cycle CRISPR Critical Care Medicine Development and progression Gene expression Genetic aspects Health aspects Hematology Intensive Interferon regulatory factor 4 Internal Medicine Letter Medical research Medicine Medicine & Public Health Multiple myeloma Oncology Oncology, Experimental Transcription factors |
| title | The transcription factor IRF4 represses proapoptotic BMF and BIM to licence multiple myeloma survival |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T08%3A57%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20transcription%20factor%20IRF4%20represses%20proapoptotic%20BMF%20and%20BIM%20to%20licence%20multiple%20myeloma%20survival&rft.jtitle=Leukemia&rft.au=Fedele,%20Pasquale%20L.&rft.date=2021-07-01&rft.volume=35&rft.issue=7&rft.spage=2114&rft.epage=2118&rft.pages=2114-2118&rft.issn=0887-6924&rft.eissn=1476-5551&rft_id=info:doi/10.1038/s41375-020-01078-0&rft_dat=%3Cgale_proqu%3EA667501888%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2548388911&rft_id=info:pmid/&rft_galeid=A667501888&rfr_iscdi=true |